Evaluation of Protective Immunity of Peptide Vaccines Composed of a 15-mer N-terminal Matrix Protein 2 and a Helper T-Cell Epitope Derived from Influenza A Virus
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The matrix protein 2 of influenza A virus (IFAV) has a relatively conserved ectodomain (M2e) composed of 23 amino acids, and M2e-based vaccines have been suggested to induce broad protective immunity in mice. In this study, we investigated whether N-terminal sequence of M2e (nM2e)-based vaccines with more conserved nM2e could induce influenza viral neutralizing activity. We constructed linear peptide vaccines with an nM2e sequence for PR8 virus (nM2Pr) connected to a probable 17-mer IFAV-derived helper T-cell epitope (ThE: T1, T2, or T3) at its N- or C-terminus. The peptide vaccines induced significant production of nM2e Abs regardless of either type or location of the ThE-epitope in BALB/c mice, while only T3 was effective in C57BL/6 mice. The Abs against nM2Pr-T3 elicited broader binding affinities to the nM2e peptides derived from various IFAVs than those against T3-nM2Pr. In addition, the nM2e-based vaccines efficiently protected the immunized mice from the lethal challenge of PR8 virus. These results suggest that the more conserved nM2e without cysteine will be useful for development of universal peptide vaccines than M2e.
Abstract
The matrix protein 2 of influenza A virus (IFAV) has a relatively conserved ectodomain (M2e) composed of 23 amino acids, and M2e-based vaccines have been suggested to induce broad protective immunity in mice. In this study, we investigated whether N-terminal sequence of M2e (nM2e)-based vaccines with more conserved nM2e could induce influenza viral neutralizing activity. We constructed linear peptide vaccines with an nM2e sequence for PR8 virus (nM2Pr) connected to a probable 17-mer IFAV-derived helper T-cell epitope (ThE: T1, T2, or T3) at its N- or C-terminus. The peptide vaccines induced significant production of nM2e Abs regardless of either type or location of the ThE-epitope in BALB/c mice, while only T3 was effective in C57BL/6 mice. The Abs against nM2Pr-T3 elicited broader binding affinities to the nM2e peptides derived from various IFAVs than those against T3-nM2Pr. In addition, the nM2e-based vaccines efficiently protected the immunized mice from the lethal challenge of PR8 virus. These results suggest that the more conserved nM2e without cysteine will be useful for development of universal peptide vaccines than M2e.
참고문헌 (23)
- Taubenberger JK, "The pathology of influenza virus infections", Annu Rev Pathol, 3, pp.499~522 (2008)
- Palese P, "Influenza: old and new threats", Nat Med, 10(Suppl), pp.S82~S87 (2004)
- Campbell CH, "Strains of Hong Kong influenza virus in calves", J Infect Dis, 135, pp.678~680 (1977)
- Trifonov V, "Geographic dependence, surveillance, and origins of the 2009influenza A (H1N1) virus", N Engl J Med, 361, pp.115~119 (2009)
- Nachbagauer R, "Universal influenza virus vaccines and therapeutic antibodies", Clin Microbiol Infect, 23, pp.222~228 (2017)
- Taubenberger JK, "Influenza: the once and future pandemic", Public Health Rep, 125(Suppl 3), pp.16~26 (2010)
- Schrauwen EJ, "Host adaptation and transmission of influenza A viruses in mammals", Emerg Microbes Infect, 3, pp.e9~ (2014)
- Heaton NS, "Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins", Proc Natl Acad Sci U S A, 110, pp.20248~20253 (2013)
- Gerdil C, "The annual production cycle for influenza vaccine", Vaccine, 21, pp.1776~1779 (2003)
- Deng L, "M2e-based universal influenza a vaccines", Vaccines (Basel), 3, pp.105~136 (2015)
- Lamb RA, "Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus", Virology, 112, pp.729~737 (1981)
- Schnell JR, "Structure and mechanism of the M2 proton channel of influenza A virus", Nature, 451, pp.591~595 (2008)
- Neirynck S, "A universal influenza A vaccine based on the extracellular domain of the M2 protein", Nat Med, 5, pp.1157~1163 (1999)
- Ma JH, "An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge", Virol J, 10, pp.227~ (2013)
- Bodewes R, "Vaccination against seasonal influenza A", H3N2 virus reduces the induction of heterosubtypic immunity against influenza A, J Virol, pp.2011, 85[DOI]
- 이유나, "Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines", Immune Network, 15(5), pp.213~221 (2015), 대한면역학회[DOI]
- Tan PT, "Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines", PLoS One, 5, pp.e8754~ (2010)
- Winter G, "Cloning of influenza cDNA ino M13: the sequence of the RNA segment encoding the A", PR, 34 matrix protein, pp.Nucleic Acids Res, 1980[DOI]
- 권동혁, "Replication and Pathogenesis of the Pandemic (H1N1) 2009 Influenza Virus in Mammalian Models", The Journal of Microbiology, 48(5), pp.657~662 (2010), 한국미생물학회
- Lee YJ, "Highly pathogenic avian influenza virus (H5N1) in domestic poultry and relationship with migratory birds, South Korea", Emerg Infect Dis, 14, pp.487~490 (2008)
- Kim HR, "Characterization of H5N2 influenza viruses isolated in South Korea and their influence on the emergence of a novel H9N2 influenza virus", J Gen Virol, 91, pp.1978~1983 (2010)
- Suarez DL, "Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong", J Virol, 72, pp.6678~6688 (1998)
- Zhang J, "Modulation of nonneutralizing HIV-1 gp41 responses by an MHCrestricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies", J Immunol, 192, pp.1693~1706 (2014)